Azitra (AZTR) Enterprise Value (2022 - 2026)
Azitra (AZTR) posted Enterprise Value of -$10.1 million for Q1 2026, down 386.01% on a QoQ basis from -$2.1 million in Q4 2025, and down 213.44% year-over-year from $8.9 million in Q1 2025.
Azitra (AZTR) Enterprise Value (2022 - 2026) Analysis & Trends
Azitra's Enterprise Value history runs 5 years deep, the most recent figure standing at -$10.1 million for Q1 2026.
- Quarterly Enterprise Value fell 213.44% year-over-year to -$10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.1 million (down 213.44% YoY) and the FY2025 annual result came in at -$2.1 million, up 54.59% from the prior year.
- Enterprise Value was -$10.1 million for Q1 2026 at Azitra, down from -$2.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$803082.0 in Q2 2024 and bottomed at -$10.1 million in Q1 2026.
- A 5-year average of -$3.8 million and a median of -$3.2 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 87.23% — and 2026, when it plunged 213.44%.
- Azitra's Enterprise Value stood at -$3.5 million in 2022, then soared by 48.58% to -$1.8 million in 2023, then sank by 153.61% to -$4.6 million in 2024, then jumped by 54.59% to -$2.1 million in 2025, then tumbled by 386.01% to -$10.1 million in 2026.
- Business Quant data shows AZTR's Enterprise Value at -$10.1 million in Q1 2026, -$2.1 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | -60.03 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -2.83 Mn |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | -4.79 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | -7.25 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | -8.75 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | -5.18 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | -3.01 Bn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | -1.91 Bn |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | -10.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.05 Mn |
| Dec 31, 2025 | -2.07 Mn |
| Sep 30, 2025 | -1.40 Mn |
| Jun 30, 2025 | -1.05 Mn |
| Mar 31, 2025 | -3.21 Mn |
| Dec 31, 2024 | -4.55 Mn |
| Sep 30, 2024 | -7.26 Mn |
| Jun 30, 2024 | -803,082.00 |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | -1.80 Mn |
| Sep 30, 2023 | -4.40 Mn |
| Jun 30, 2023 | -6.29 Mn |
| Dec 31, 2022 | -3.49 Mn |